| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/04/2002 | US20020086823 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086822 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086821 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086820 Respiratory system related polynucleotides and polypeptides (antigens) for detection/diagnosis of cancer |
| 07/04/2002 | US20020086819 Conjugating polymer (polyethylene glycol) to biologically active molecule (polypeptide); human urokinase plasminogen activator |
| 07/04/2002 | US20020086817 Mannan-binding protein or gene; vaccinia virus vectors |
| 07/04/2002 | US20020086816 For transplants; to prevent rise in hemoglobin concentrations and hematocrit during therapy; perfusion; preservation |
| 07/04/2002 | US20020086815 Cancer therapy; for skin cancer, myeloids |
| 07/04/2002 | US20020086813 Mutants of streptococcal toxin a and methods of use |
| 07/04/2002 | US20020086812 Gene expression inhibition; for treatment of cancer of pancreas, lungs, prostates, livers, ovaries, cervices, and/or breasts; drug delivery |
| 07/04/2002 | US20020086811 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086444 Isolated menbrane protein for use in the diagnosis and treatment of alzheimer's disease |
| 07/04/2002 | US20020086420 Novel antiangiogenic peptides |
| 07/04/2002 | US20020086414 Novel ctla4/cd28 ligands and uses therefor |
| 07/04/2002 | US20020086411 Defective adenovirus for use in the treatment of tumors |
| 07/04/2002 | US20020086409 Methods and compounds for modulating male fertility |
| 07/04/2002 | US20020086408 Ubiquitin-like conjugating protein |
| 07/04/2002 | US20020086405 56638, a novel human neprilysin protease and uses thereof |
| 07/04/2002 | US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer |
| 07/04/2002 | US20020086401 Nucleotide sequences coding transport protein; for use generating antiproliferative agents |
| 07/04/2002 | US20020086400 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 07/04/2002 | US20020086396 Human transcription factor IIA |
| 07/04/2002 | US20020086394 Enzymatic polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and nervous system disorders |
| 07/04/2002 | US20020086393 Mitochondrial adenylate kinase |
| 07/04/2002 | US20020086391 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses therof |
| 07/04/2002 | US20020086390 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of cancer and cell proliferation defects |
| 07/04/2002 | US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides |
| 07/04/2002 | US20020086384 Nucleotide sequences coding transcription regulatory sequence for use in the diagnosis, prevention and treatment of cancer |
| 07/04/2002 | US20020086383 Cell expansion factor; for use in the treatment and prevention of graft rejection |
| 07/04/2002 | US20020086382 Nucleotide sequences coding membrane protein for use in the prevention and treatment of autoimmune diseases |
| 07/04/2002 | US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/04/2002 | US20020086379 Human membrane-spanning proteins |
| 07/04/2002 | US20020086368 Human toll homologues |
| 07/04/2002 | US20020086364 Protein for use in the treatment and prevention of cancer, autoimmune, respiratory, bone and nervous system disorders, inflammation, Crohn's disease and bacterial infections; wound healing agents |
| 07/04/2002 | US20020086361 Polypeptide for use in detecting cancer and treating osteoporosis |
| 07/04/2002 | US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke |
| 07/04/2002 | US20020086356 Preferential nucleotide sequences for controlling preferential ribonucleic acids; for use in therapeutic genomics; for gene therapy |
| 07/04/2002 | US20020086354 Nucleotide sequences coding preferential polypeptide for use in the treatment and prevention of cell proliferative disorders |
| 07/04/2002 | US20020086352 Methods for expressing endostatin protein |
| 07/04/2002 | US20020086351 Human nodal and lefty homologues |
| 07/04/2002 | US20020086348 Tolerogenic fragments of natural allergens |
| 07/04/2002 | US20020086343 Diagnosing the intensity of a pain in humans; obtain sample, monitor sample for marker gene expression, correlate marker expression with pain |
| 07/04/2002 | US20020086334 Human protease molecules |
| 07/04/2002 | US20020086331 Crystal structure of worm NitFhit reveals that a Nit tetramer binds two Fhit dimers |
| 07/04/2002 | US20020086321 Myeloid cell leukemia associated gene MCL-1 |
| 07/04/2002 | US20020086320 Detecting prostate cancer gene in test sample; obtain nucleotide sequence sample, incubate with probe, detect signal for from probes bound to target sequences |
| 07/04/2002 | US20020086316 Reagents and methods useful for detecting diseases of the prostate |
| 07/04/2002 | US20020086305 Human c-Maf compositions and methods of use thereof |
| 07/04/2002 | US20020086304 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 07/04/2002 | US20020086301 Reagents and methods useful for detecting diseases of the prostate |
| 07/04/2002 | US20020086297 Gene alteration in the gene for the Gbeta3-subunit of the human G protein |
| 07/04/2002 | US20020086296 26583, a novel serine/threonine phosphatase and uses therefor |
| 07/04/2002 | US20020086070 For therapy of osteoarthritis and rheumatoid arthritis, as well as connective tissue damaged by trauma or injury |
| 07/04/2002 | US20020086063 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
| 07/04/2002 | US20020086048 Design and application method for enhanced oral assimilation through the oral mucosa and/or intestinal membranes, of liquids containing nutrients, nutraceuticals or drugs, which are encapsulated in natural and/or synthetic liposomal vesicles |
| 07/04/2002 | US20020086036 Therapy of hyperhidrosis (excessive sweating) in a mammal, by locally administering a drug particle to an affected skin area without using a needle |
| 07/04/2002 | US20020086034 Compositions and methods for treating viral infections |
| 07/04/2002 | US20020086030 Preparations and methods for the treatment of t cell mediated diseases |
| 07/04/2002 | US20020086025 Antibodies that bind to alpha2-antiplasmin crosslinked to fibrin which do not inhibit plasma alpha2-antiplasmin |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086020 Method for improving the half-life of soluble viral receptors on mucosal membranes |
| 07/04/2002 | US20020086019 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 07/04/2002 | US20020086018 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI |
| 07/04/2002 | US20020086017 GA binding protein and neurite derived growth factors for use in the treatment of muscular dystrophy |
| 07/04/2002 | US20020086015 Compositions and methods for promoting nerve regeneration |
| 07/04/2002 | US20020086013 Administering an agent that inhibits a component of the VEGF signal transduction pathway; agent decreases a connective tissue growth factor (CTGF) activity in the tissue of the subject. |
| 07/04/2002 | US20020086012 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 07/04/2002 | US20020086011 Administering an effective amount of an OX-2 protein or a nucleic acid encoding an OX-2 protein; use to suppress an immune response and to prevent or treat autoimmune disease, especially arthritis. |
| 07/04/2002 | US20020086010 Such as an enzyme or antimicrobial (especially lactase) ; at an elevated temperature that would normally destroy or denature the active material(s). |
| 07/04/2002 | US20020086008 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 07/04/2002 | US20020086007 Angiogenesis-inhibiting peptides and proteins and methods of use |
| 07/04/2002 | US20020086006 And polynucleotides which identify and encode MT-MDH; expression vectors, host cells, agonists, antibodies and antagonists; treating disorders associated with expression of MT-MDH. |
| 07/04/2002 | US20020086004 Especially wherein said angiogenic factor is an endothelial cell growth factor chosen from the FGF family of growth factors and the VEGF family of growth factors. |
| 07/04/2002 | US20020086003 Thymus reactivation, especially by administering hematopoietic stem cells |
| 07/04/2002 | US20020086002 Hematopoietic stem cell gene therapy |
| 07/04/2002 | US20020086001 Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| 07/04/2002 | US20020086000 Stimulation of thymus for vaccination development |
| 07/04/2002 | US20020085998 Breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 07/04/2002 | US20020085997 Tumor cells at least some of which contain at least one MHC-I-haplotype of the patient on the cell surface, and which are charged with one or more peptides binding to the MHC-I molecule |
| 07/04/2002 | US20020085992 Method for treating inflammation |
| 07/04/2002 | US20020085980 Oral care product comprising a mutan binding domain |
| 07/04/2002 | US20020084187 Using Gradiflow electrophoresis technology for macromolecule separation which utilises tangential flow across the membrane |
| 07/04/2002 | DE10065504A1 Adenoviral nucleic acid useful for preventing or treating malignant or benign tumors, by inducing cell lysis, comprises a sequence for the YB-1 protein |
| 07/04/2002 | DE10059144A1 Modulation der Transkription pro-inflammatorischer Genprodukte Modulating the transcription of pro-inflammatory gene products |
| 07/04/2002 | CA2847458A1 Defects in periaxin associated with myelinopathies |
| 07/04/2002 | CA2782510A1 Polypeptides |
| 07/04/2002 | CA2446840A1 Composition and process for bone growth and repair |
| 07/04/2002 | CA2436777A1 A screening assay for antagonists of human leukocyte receptors |
| 07/04/2002 | CA2436501A1 Educated nk t cells and their uses in the treatment of immune-related disorders |
| 07/04/2002 | CA2433171A1 Human fgf23 protein mutants decreasing blood phosphorus level |
| 07/04/2002 | CA2433116A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
| 07/04/2002 | CA2433081A1 Bioactive materials for aneurysm repair |
| 07/04/2002 | CA2432977A1 New use of artemin, a member of the gdnf ligand family |
| 07/04/2002 | CA2432927A1 Antibacterial treatments |
| 07/04/2002 | CA2432896A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 07/04/2002 | CA2432715A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | CA2432683A1 Screening method based on siah-numb interaction |
| 07/04/2002 | CA2432591A1 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1 |
| 07/04/2002 | CA2432542A1 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | CA2432327A1 Screening method based on tsap6 binding partners |